BlackRock Advisors’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $217K | Sell |
16,567
-683
| -4% | -$8.95K | ﹤0.01% | 2616 |
|
|
2016
Q3 | $297K | Buy |
17,250
+2,146
| +14% | +$36.9K | ﹤0.01% | 2399 |
|
|
2016
Q2 | $273K | Buy |
15,104
+1,769
| +13% | +$32K | ﹤0.01% | 2416 |
|
|
2016
Q1 | $253K | Sell |
13,335
-2,641
| -17% | -$50.1K | ﹤0.01% | 2399 |
|
|
2015
Q4 | $427K | Sell |
15,976
-2,786
| -15% | -$74.5K | ﹤0.01% | 2141 |
|
|
2015
Q3 | $458K | Buy |
18,762
+2,550
| +16% | +$62.2K | ﹤0.01% | 2226 |
|
|
2015
Q2 | $505K | Buy |
16,212
+3,494
| +27% | +$109K | ﹤0.01% | 2139 |
|
|
2015
Q1 | $185K | Buy |
12,718
+1,993
| +19% | +$29K | ﹤0.01% | 2691 |
|
|
2014
Q4 | $108K | Buy |
10,725
+1,490
| +16% | +$15K | ﹤0.01% | 2970 |
|
|
2014
Q3 | $77K | Buy |
9,235
+1,086
| +13% | +$9.06K | ﹤0.01% | 3099 |
|
|
2014
Q2 | $100K | Buy |
+8,149
| New | +$100K | ﹤0.01% | 3019 |
|